Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B10 | O60218 | 3/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | APP | P05067 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyl Cinnamate SCHEMBL119511 | 0.85 | APP (0.65) | AKR1B10AKR1B1ALDH1A1APPTDP1 | |
| Butyl Cinnamate SCHEMBL119510 | 0.85 | APP (0.65) | AKR1B10AKR1B1ALDH1A1APPTDP1 | |
| Butyl Cinnamate SCHEMBL5314386 | 0.85 | APP (0.65) | AKR1B10AKR1B1ALDH1A1APPTDP1 | |
| SCHEMBL28368155 | 0.84 | TDP1 (0.52) | AKR1B10AKR1B1ALDH1A1APPTDP1 | |
| SCHEMBL28368153 | 0.84 | TDP1 (0.52) | AKR1B10AKR1B1ALDH1A1APPTDP1 | |
| SCHEMBL17629134 | 0.84 | APP (0.66) | AKR1B10AKR1B1ALDH1A1APPLMNA | |
| SCHEMBL356459 | 0.84 | APP (0.66) | AKR1B10AKR1B1ALDH1A1APPLMNA | |
| SCHEMBL356458 | 0.84 | APP (0.66) | AKR1B10AKR1B1ALDH1A1APPLMNA | |
| Cinnamic Acid SCHEMBL430668 | 0.83 | HCAR2 (0.62) | AKR1B10AKR1B1ALDH1A1APPLMNA | |
| SCHEMBL32075 | 0.83 | APP (0.67) | AKR1B10AKR1B1ALDH1A1APPLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020172647-A1 | Composition containing a steroid and a liposoluble UV filter | L'OREAL (FR) | 2002-11-21 | — | — | US | claimed |
| CN-115772307-A | Modified ABS resin and preparation method thereof | 山东东临新材料股份有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-108335837-B | Transformer, transformer box body and vibration damping device for transformer box body | 中国电力科学研究院有限公司 | 2021-12-21 | — | — | CN | disclosed |
| CN-105848634-B | Oil-in-water emulsion cosmetic for skin | 株式会社高丝 | 2020-06-30 | — | — | CN | disclosed |
| US-20020172647-A1 | Composition containing a steroid and a liposoluble UV filter | L'OREAL (FR) | 2002-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020172647-A1 | Composition containing a steroid and a liposoluble UV filter | SHBG, GLA, LIPA | AKR1B10 673/4885AKR1B1 1009/4885ALDH1A1 1172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.